242 related articles for article (PubMed ID: 36789575)
21. Virus-host interactions in carcinogenesis of Epstein-Barr virus-associated gastric carcinoma: Potential roles of lost ARID1A expression in its early stage.
Abe H; Kunita A; Otake Y; Kanda T; Kaneda A; Ushiku T; Fukayama M
PLoS One; 2021; 16(9):e0256440. PubMed ID: 34469459
[TBL] [Abstract][Full Text] [Related]
22. The tumor immune composition of mismatch repair deficient and Epstein-Barr virus-positive gastric cancer: A systematic review.
Bos J; Groen-van Schooten TS; Brugman CP; Jamaludin FS; van Laarhoven HWM; Derks S
Cancer Treat Rev; 2024 Jun; 127():102737. PubMed ID: 38669788
[TBL] [Abstract][Full Text] [Related]
23. Expression and significance of EBV, ARID1A and PIK3CA in gastric carcinoma.
Zhou H; Tan S; Li H; Lin X
Mol Med Rep; 2019 Mar; 19(3):2125-2136. PubMed ID: 30747208
[TBL] [Abstract][Full Text] [Related]
24. Clinicopathological features of tumor mutation burden, Epstein-Barr virus infection, microsatellite instability and PD-L1 status in Chinese patients with gastric cancer.
Zhang L; Wang Y; Li Z; Lin D; Liu Y; Zhou L; Wang D; Wu A; Li Z
Diagn Pathol; 2021 May; 16(1):38. PubMed ID: 33933102
[TBL] [Abstract][Full Text] [Related]
25. Loss of ARID1A expression and its relationship with PI3K-Akt pathway alterations, TP53 and microsatellite instability in endometrial cancer.
Bosse T; ter Haar NT; Seeber LM; v Diest PJ; Hes FJ; Vasen HF; Nout RA; Creutzberg CL; Morreau H; Smit VT
Mod Pathol; 2013 Nov; 26(11):1525-35. PubMed ID: 23702729
[TBL] [Abstract][Full Text] [Related]
26. An Integrative Morphomolecular Classification System of Gastric Carcinoma With Distinct Clinical Outcomes.
Tsai JH; Jeng YM; Chen KH; Lee CH; Yuan CT; Liau JY
Am J Surg Pathol; 2020 Aug; 44(8):1017-1030. PubMed ID: 32568823
[TBL] [Abstract][Full Text] [Related]
27. Young-onset gastric cancer and Epstein-Barr Virus (EBV) - a major player in the pathogenesis?
Moore A; Hikri E; Goshen-Lago T; Barkan T; Morgenstern S; Brook E; Maderer A; Roth W; Gordon N; Kashtan H; Brenner B; Moehler M; Aharon IB
BMC Cancer; 2020 Jan; 20(1):34. PubMed ID: 31937281
[TBL] [Abstract][Full Text] [Related]
28. Epstein-Barr virus-associated gastric cancer: disease that requires special approach.
Ignatova E; Seriak D; Fedyanin M; Tryakin A; Pokataev I; Menshikova S; Vakhabova Y; Smirnova K; Tjulandin S; Ajani JA
Gastric Cancer; 2020 Nov; 23(6):951-960. PubMed ID: 32514646
[TBL] [Abstract][Full Text] [Related]
29. Prevalence of Epstein-Barr Virus Infection and Mismatch Repair Protein Deficiency and the Correlation of Immune Markers in Tibetan Patients with Gastric Cancer.
Shi J; Yang X; Wang X; Luo Y; Zhou W; Luo H; Bianba Z; Nima Z; Wang Q; Wang H; Liao R; Ciren Q; Li M; Pang J
Biomed Res Int; 2022; 2022():2684065. PubMed ID: 35734348
[TBL] [Abstract][Full Text] [Related]
30. Preservation of Epstein-Barr virus status and mismatch repair protein status along the metastatic course of gastric cancer.
Dislich B; Blaser N; Berger MD; Gloor B; Langer R
Histopathology; 2020 Apr; 76(5):740-747. PubMed ID: 31898331
[TBL] [Abstract][Full Text] [Related]
31. Contributions of the Epstein-Barr virus EBNA1 protein to gastric carcinoma.
Sivachandran N; Dawson CW; Young LS; Liu FF; Middeldorp J; Frappier L
J Virol; 2012 Jan; 86(1):60-8. PubMed ID: 22013060
[TBL] [Abstract][Full Text] [Related]
32. Various ARID1A expression patterns and their clinical significance in gastric cancers.
Kim YB; Ham IH; Hur H; Lee D
Hum Pathol; 2016 Mar; 49():61-70. PubMed ID: 26826411
[TBL] [Abstract][Full Text] [Related]
33. ARID1A genomic alterations driving microsatellite instability through somatic MLH1 methylation with response to immunotherapy in metastatic lung adenocarcinoma: a case report.
Durán M; Faull I; Lastra E; Laes JF; Rodrigo AB; Sánchez-Escribano R
J Med Case Rep; 2021 Feb; 15(1):89. PubMed ID: 33608032
[TBL] [Abstract][Full Text] [Related]
34. Loss of ARID1A Expression in Gastric Cancer: Correlation with Mismatch Repair Deficiency and Clinicopathologic Features.
Kim KJ; Jung HY; Oh MH; Cho H; Lee JH; Lee HJ; Jang SH; Lee MS
J Gastric Cancer; 2015 Sep; 15(3):201-8. PubMed ID: 26468418
[TBL] [Abstract][Full Text] [Related]
35. Clinical outcome and molecular landscape of patients with ARID1A-loss gastric cancer.
Sun M; Gu Y; Fang H; Shao F; Lin C; Zhang H; Li H; He H; Li R; Wang J; Liu H; Xu J
Cancer Sci; 2024 Mar; 115(3):905-915. PubMed ID: 38148578
[TBL] [Abstract][Full Text] [Related]
36. Morphological Features and Prognostic Significance of ARID1A-Deficient Esophageal Adenocarcinomas.
Drage MG; Tippayawong M; Agoston AT; Zheng Y; Bueno R; Hornick JL; Odze RD; Srivastava A
Arch Pathol Lab Med; 2017 Jul; 141(7):970-977. PubMed ID: 28440661
[TBL] [Abstract][Full Text] [Related]
37. Gastric Carcinomas With Lymphoid Stroma: An Evaluation of the Histopathologic and Molecular Features.
Hissong E; Ramrattan G; Zhang P; Zhou XK; Young G; Klimstra DS; Shia J; Fernandes H; Yantiss RK
Am J Surg Pathol; 2018 Apr; 42(4):453-462. PubMed ID: 29438172
[TBL] [Abstract][Full Text] [Related]
38. Alteration in stemness causes exclusivity between Epstein-Barr virus-positivity and microsatellite instability status in gastric cancer.
Kim Y; Shin YJ; Wen X; Cho NY; Li M; Kim YJ; Song SH; Kang GH
Gastric Cancer; 2021 May; 24(3):602-610. PubMed ID: 33386473
[TBL] [Abstract][Full Text] [Related]
39. Epstein-Barr virus-associated lymphoepithelioma-like gastric carcinoma.
Herath CH; Chetty R
Arch Pathol Lab Med; 2008 Apr; 132(4):706-9. PubMed ID: 18384225
[TBL] [Abstract][Full Text] [Related]
40. Intratumoral heterogeneity and loss of ARID1A expression in gastric cancer correlates with increased PD-L1 expression in Western patients.
Tober JM; Halske C; Behrens HM; Krüger S; Röcken C
Hum Pathol; 2019 Dec; 94():98-109. PubMed ID: 31704366
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]